Table of Content - Infantile Spasm Treatment Market

Infantile spasm is a rare disorder that appears as seizures in infants below 1 year. Infantile spasm causes series of sudden, jerking movements of legs and arms or fast drop of head. The duration of spasm can last up to couple of seconds. Major drugs used for the treatment of infantile spasm include adrenocorticotropic hormone (ACTH), however, due to its side effects, doctors also prefer anti-seizure drugs such as vigabatrin and other steroid therapies.

Market Dynamics

Increasing prevalence of central nervous system infection, may develop infantile spasm which in turn is expected to boost the infantile spasm treatment market. According to the National Center for Biotechnology Information (NCBI), in January 2018, the prevalence of infantile spasm was 2 to 3.5 infants per 10,000 live births.

Government initiatives for rare disease treatment is expected to boost the market growth. For instance, The American Academy of Pediatrics also works with the Child Neurology Society, Child Neurology Foundation, American College of Emergency Physicians, and other partners to build advocacy, identify awareness gaps, and expand outreach opportunities.

The relapse or reoccurrence of infantile spasm is a major factor driving growth of the infantile spasm treatment market. According to investigators from Okayama University Hospital, Japan, after the treatment of infantile spasm with ACTH therapy for 11 to 37 days, the disease reoccurred in 41% of the people under study.

Moreover, the government of Brazil in year 2017 amended its regulatory rules for approving drugs for rare disease. In December 2017, Brazilian regulatory agency, Agência Nacional de Vigilância Sanitária (ANVISA) published Resolution RDC 205/2017, regulating special procedures for clinical trials, registration, and certification of Good Manufacturing Practices (GMPs) of drugs intended to treat, prevent or diagnose rare diseases such as infantile spasm.

Key features of the study

This report provides in-depth analysis of the infantile spasm treatment market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global infantile spasm treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include H. Lundbeck A/S, Mallinckrodt Pharmaceuticals, Catalyst Pharmaceuticals, GW Pharmaceuticals plc, Retrophin, Inc., Valerion Therapeutics, Orphelia Pharma SA, Insys Therapeutics, Inc., and Anavex Life Sciences Corp.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global infantile spasm treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the infantile spasm treatment market

Market Segmentation

By Product Type
- Adrenocorticotropic Hormone
- Vigabatrin
- Phase III
By Route of Administration
- Oral
- Parenteral
By Regional Insights
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - North Africa
  - Central Africa
Key Players Insights
- Lundbeck A/S
- Mallinckrodt Pharmaceuticals
- Catalyst Pharmaceuticals
- GW Pharmaceuticals plc
- Retrophin, Inc.
- Valerion Therapeutics
- Orphelia Pharma SA
- Insys Therapeutics, Inc.
- Anavex Life Sciences Corp.

Table of Contents

Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

Market Purview

Report Description

Market Definition and Scope

Executive Summary

Market Snippet, By Product Type
Market Snippet, By Route of Administration
Market Snippet, By Region

Coherent Opportunity Map (COM)

Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
PEST Analysis
PORTER’s Five Forces Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trend

Global Infantile Spasm Treatment Market , By Product Type, 2026-2033, (USD Bn)

Introduction

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Adrenocorticotropic Hormone

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends

Vigabatrin

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends

Phase III

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Global Infantile Spasm Treatment Market , By Route of Administration, 2026-2033, (USD Bn)

Introduction

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Oral

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends

Parenteral

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends

Global Infantile Spasm Treatment Market , By Region, 2026-2033, (USD Bn)

Introduction

Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Region, 2021 - 2033

North America

Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)

U.S.
Canada

Latin America

Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)

Brazil
Argentina
Mexico
Rest of Latin America

Europe

Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Middle East

Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)

GCC Countries
Israel
Rest of Middle East

Africa

Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)

South Africa
North Africa
Central Africa

Competitive Landscape

Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles

H. Lundbeck A/S

Company Overview
Product Type Portfolio
Recent Developments/Updates

Mallinckrodt Pharmaceuticals

Company Overview
Product Type Portfolio
Recent Developments/Updates

Catalyst Pharmaceuticals

Company Overview
Product Type Portfolio
Recent Developments/Updates

GW Pharmaceuticals plc

Company Overview
Product Type Portfolio
Recent Developments/Updates

Retrophin, Inc.

Company Overview
Product Type Portfolio
Recent Developments/Updates

Valerion Therapeutics

Company Overview
Product Type Portfolio
Recent Developments/Updates

Orphelia Pharma SA

Company Overview
Product Type Portfolio
Recent Developments/Updates

Insys Therapeutics, Inc.

Company Overview
Product Type Portfolio
Recent Developments/Updates

Anavex Life Sciences Corp.

Company Overview
Product Type Portfolio
Recent Developments/Updates

Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

Section

References
Research Methodology
About Us and Sales Contact

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now